Solid Tumor Protocols / Clinical Studies

For information on these and other studies, referring physicians may e-mail protocolinfo@stjude.org or call toll free physician referral line, 1-888-226-4343. If you are not a physician, please e-mail info@stjude.org for information on St. Jude studies.

 

International Pediatric Adrenocortical Tumor Registry Data Collection

For: adrenocortical carcinoma

 
 

A Phase I Trial of the Combination of Oxaliplatin and Etoposide in Recurrent or Refractory Pediatric Solid Tumors and Lymphomas

For: Recurrent or refractory solid tumors or lymphomas

 
 

A Dose Finding Study (Phase I) of the Combination of ZD1839 (Iressa®) and Irinotecan (CamptosarTM) Given Orally in Children with Refractory Solid Tumors (AstraZeneca Protocol IRUSIRES0181)

For: Refractory solid tumors including glioblastoma, rhabdomyosarcoma, neuroblastoma, and osteosarcoma

 
 

Protocol for the Study and Treatment of Patients with Intraocular Retinoblastoma

For: Retinoblastoma

 
 

Image Guided Radiotherapy for the Treatment of Musculoskeletal Tumors: A Phase II Prospective Evaluation of Radiation-related Treatment Effects

For: Ewing sarcoma; rhabdomyosarcoma; primitive neuroectodermal tumors (PNET) of the musculoskeletal system; soft tissue sarcomas; other bone sarcomas; chordoma

 
 

Allogeneic Bone Marrow Transplantation for Children with Solid Malignancies

For: Solid tumors, Lymphoma

 

Non St. Jude Protocols

 

Perinatal Neuroblastoma: Expectant Observation - A Children's Oncology Group Pilot Study

For: Neuroblastoma

 
 

A Phase III Study of Reduced Therapy in the Treatment of Children with Low and Intermediate Risk Extracranial Germ Cell Tumors (AGCT0132)

For: Germ cell tumor

 
 

Treatment of Childhood Nasopharyngeal Carcinoma with Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy

For: Nasopharyngeal carcinoma

 
 

A Phase II Study of Sulindac and Tamoxifen in Patients with Desmoid Tumors that are Recurrent or Not Amenable to Standard Therapy (ARST0321)

For: Desmoid Tumor (also known as fibromatosis)

 
 

Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide with or without Radiation Therapy for Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma

For: Rhabdomyosarcoma (embryonal/botryoid/spindle cell subtypes)

 
Email This Article Email This Article   |   Print Print